Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials
In Brief: NIH Reviewers, Advisors To Get Increase In Honoraria; Price Leaving NCI for Maryland
Recision, 1981 Budget Threats Hangover NCI
Frelick Heads ACCC, Kerman Names President-Elect
CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients
Skipper To Receive Bristol-Myers Award
Pathology Review Confirms Reserpine As Carcinogen
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









